Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the quadrivalent market right now?

The size of the quadrivalent market has experienced robust growth in the past few years. The market is anticipated to increase from $8.87 billion in 2024 to $9.61 billion in 2025, facilitating a compound annual growth rate (CAGR) of 8.2%. Factors such as the complexity of diseases, educational drives, previous health incidents, enhancement in healthcare, and technological advancements contribute to the growth observed during the historic period.

How fast Is the quadrivalent market expected to grow, and what’s its future value?

Anticipated to expand swiftly over the ensuing years, the quadrivalent market is predicted to escalate to a substantial $14.22 billion by 2029, boasting a compound annual growth rate (CAGR) of 10.3%. A myriad of factors can be accredited to driving this growth in the projected timeframe – these include global health phenomena, competitive forces, educational drives, regulatory shifts, and changing disease patterns. Key trends to look out for during this forecast period encompass disease frequency, regulatory framework, development in healthcare infrastructure, heightened consumer awareness and education, along with alterations in the competitive arena.

Get your quadrivalent market report here!

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

What are the leading drivers of growth in the quadrivalent market?

The quadrivalent market’s growth is anticipated to be driven by the increasing incidence of both chronic and infectious diseases. Chronic diseases are persistent illnesses that are usually a result of genetics and lifestyle, while infectious diseases come about due to exposure to infectious organisms such as viruses, bacteria, fungi, or protozoans. Quadrivalent vaccines play a pivotal role in preventing severe infections and diseases, in addition to ailments that are not specifically their target. These vaccines are utilised to avert chronic (non-communicable) diseases when infectious agents are implicated in the development of cancer. The Centers for Disease Control and Prevention, an American non-profit organisation, reported in September 2024 that in week 37, 0.5% of specimens tested were positive for influenza. Out of these, 91.4% were influenza A, the remaining 8.6% were influenza B. Since October 1st, 2023 (Week 40), cumulative data shows 8.7% of specimens tested positive, with 69.2% being influenza A and 30.8% influenza B. This data highlights an increasing positivity rate and a growing fraction of influenza B cases over time. Consequently, the escalating incidence of chronic and infectious diseases is propelling the growth of the quadrivalent market.

What are the key segments defining the quadrivalent market?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Who are the key players steering the development of the quadrivalent market?

Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

What emerging trends are influencing the growth of the quadrivalent market?

In the quadrivalent market, the rise of product innovations is a prominent trend. Many major firms in this sector are concentrating on the creation of novel solutions to solidify their market presence. As an illustration, in September 2022, AstraZeneca, a pharmaceutical enterprise based in the UK, introduced FluMist quadrivalent (Influenza Vaccination Live, Intranasal), an FDA-approved flu vaccine delivered via a needle-free nasal spray suitable for individuals aged 2 to 49. This live attenuated influenza vaccine is available in both trivalent and quadrivalent versions and is included in most health insurance plans, as well as the children’s vaccination program.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9335

Which regions are most influential in expanding the quadrivalent market?

North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Product Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report

Ventricular Assist Device Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: